PAPER Banack SA, Downing TG, Spácil Z, Purdie EL, Metcalf JS, Downing S, Esterhuizen M, Codd GA, Cox PA
SEARCH RESULTS
329963 RESULTS
PAPER Redel P, Bublak P, Sorg C, Kurz A, Förstl H, Müller HJ, Schneider WX, Perneczky R, Finke K
Deficits of spatial and task-related attentional selection in mild cognitive impairment and Alzheimer's disease.
Neurobiol Aging. 2012 Jan;33(1):195.e27-42. PubMed: 20561715PAPER Qu BX, Lambracht-Washington D, Fu M, Eagar TN, Stüve O, Rosenberg RN
Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.
Vaccine. 2010 Jul 19;28(32):5280-7. PubMed: 20562015PAPER Bachar AR, Scheffer L, Schroeder AS, Nakamura HK, Cobb LJ, Oh YK, Lerman LO, Pagano RE, Cohen P, Lerman A
Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress.
Cardiovasc Res. 2010 Nov 1;88(2):360-6. PubMed: 20562421PAPER Pretnar-Oblak J, Zaletel M, Hajnsek TM, Meglic B, Hocevar-Boltezar I, Popovic M
Isolated bulbar paralysis in a patient with medullar tau pathology: a case report.
J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):847-9. PubMed: 20562453PAPER Dickerson BC, Wolk DA,
Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.
J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):45-51. PubMed: 20562467PAPER Wattmo C, Wallin AK, Londos E, Minthon L
Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
Gerontologist. 2011 Feb;51(1):17-27. PubMed: 20562471PAPER Dev H, Agius M, Zaman R
The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease.
Psychiatr Danub. 2010 Jun;22(2):367-9. PubMed: 20562785PAPER Presecki P, Mihanović M, Mimica N
Cognitive impairment and general anaesthesia- Case report.
Psychiatr Danub. 2010 Jun;22(2):385-6. PubMed: 20562790PAPER Skorobogatko YV, Deuso J, Adolf-Bergfoyle J, Nowak MG, Gong Y, Lippa CF, Vosseller K
Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.
Amino Acids. 2011 Mar;40(3):765-79. PubMed: 20563614PAPER Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD, Van Eldik LJ, Markesbery WR
Association between male gender and cortical Lewy body pathology in large autopsy series.
J Neurol. 2010 Nov;257(11):1875-81. PubMed: 20563821PAPER Kinouchi T, Matsuda A, Kawakami S, Shimizu T, Shirasawa T, Fujii N
Influence of oxidative stress on D-aspartyl endopeptidase activity.
Chem Biodivers. 2010 Jun;7(6):1398-402. PubMed: 20564553PAPER Sadakane Y, Konoha K, Kawahara M, Nakagomi K
Quantification of structural alterations of L-Asp and L-Asn residues in peptides related to neuronal diseases by reversed-phase high-performance liquid chromatography.
Chem Biodivers. 2010 Jun;7(6):1371-9. PubMed: 20564556PAPER Kinouchi T, Fujii N
Structural consideration of mammalian D-aspartyl endopeptidase.
Chem Biodivers. 2010 Jun;7(6):1403-7. PubMed: 20564558PAPER Ambegaokar SS, Roy B, Jackson GR
Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis.
Neurobiol Dis. 2010 Oct;40(1):29-39. PubMed: 20561920Current Filters
No filters selected